Literature DB >> 2471811

Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.

P V Barnett1, E J Ouldridge, D J Rowlands, F Brown, N R Parry.   

Abstract

Eleven neutralizing monoclonal antibodies (MAbs) were produced to the O1BFS 1860/67 strain of foot-and-mouth disease virus (FMDV), and were characterized for their ability to bind viral and subviral antigens in different ELISA tests and to neutralize heterologous type O isolates. Neutralization escape variants of the homologous virus, isolated under pressure from five of these MAbs, were used in cross-neutralization tests with all of the 11 antibodies. These studies identified three functionally independent, conformational, neutralizing sites. The most conformationally dependent site bound antibody which neutralized a range of type O virus isolates. A second site was less dependent on conformation and was recognized by antibody that was strain-specific. The least conformational site bound MAbs which showed limited cross-neutralization of other type O strains. This latter site appeared to be immunodominant and contained several overlapping epitopes which showed some differences in their specificities. Isoelectrofocusing and sequencing studies of the variants strongly suggested that polypeptide VP2 contributes to the immunodominant site.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471811     DOI: 10.1099/0022-1317-70-6-1483

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  25 in total

1.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

Authors:  M J Gonzalez; J C Saiz; O Laor; D M Moore
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Characterization of monoclonal antibodies against a type SAT 2 foot-and-mouth disease virus.

Authors:  J R Crowther; C A Rowe; R Butcher
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

4.  Development of an Indirect Chemiluminescence Immunoassay Using a Multiepitope Recombinant Protein To Specifically Detect Antibodies against Foot-and-Mouth Disease Virus Serotype O in Swine.

Authors:  Wei Liu; Junjun Shao; Guanglei Zhang; Yanyan Chang; Sudan Ge; Yue Sun; Zhan Gao; Huiyun Chang
Journal:  J Clin Microbiol       Date:  2021-02-18       Impact factor: 5.948

5.  Fine mapping of a foot-and-mouth disease virus epitope recognized by serotype-independent monoclonal antibody 4B2.

Authors:  Yongzhong Yu; Haiwei Wang; Lei Zhao; Chunyuan Zhang; Zhigang Jiang; Li Yu
Journal:  J Microbiol       Date:  2011-03-03       Impact factor: 3.422

6.  Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11.

Authors:  N D Christensen; J W Kreider; N M Cladel; S D Patrick; P A Welsh
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Characterization of neutralizing antibodies to bovine enterovirus elicited by synthetic peptides.

Authors:  M S Smyth; A Trudgett; E M Hoey; S J Martin; F Brown
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide.

Authors:  T R Doel; C M Doel; R F Staple; R DiMarchi
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle.

Authors:  M J van Lierop; K van Maanen; R H Meloen; V P Rutten; M A de Jong; E J Hensen
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.